Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 220
Selected: 0
NCT IDTitle
NCT07041788Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
NCT06949761A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
NCT07061639A Study of QLS5133 Monotherapy in Advanced Solid Tumors
NCT04859751Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer
NCT07089186Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
NCT06936748SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors
NCT05528198Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers
NCT06383767A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
NCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT05554913Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia
NCT06750341Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol
NCT05150405A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors
NCT05058105Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)
NCT06254235Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
NCT07489599A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
NCT05149924Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment
NCT05758519A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19
NCT07178171A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
NCT06754644A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC
NCT06932094Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors
NCT07062978A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
NCT06884891A Phase Ⅲ Comparative Study of QL2108 to Dupixent®
NCT05976568A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
NCT02908958Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
NCT05278832A Study of QLS31905 in Patients With Advanced Solid Tumors
NCT03389815A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients
NCT07313150A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults
NCT05801094A Phase I Study of QL1604 for Advanced Solid Tumors
NCT06822985QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma
NCT06980909The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects
NCT07441317QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)
NCT06749899QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
NCT07138209A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT06649214A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia
NCT06644495Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib
NCT05801107Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
NCT07453394QLS5132 Combination Therapy in Advanced Solid Tumors
NCT05531994Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers
NCT06456528QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
NCT05060419Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections
NCT07004335Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study
NCT06898060To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
NCT04651036A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
NCT05629949A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer
NCT07511647A Phase 3 Clinical Study of QL2106 Injection
NCT06742216Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study
NCT07487103Efficacy and Safety of QLG1090 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
NCT03312283Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD
NCT06852456QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma
NCT06686576A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer